Wanxin Su

Title: Wanxin Su: Innovator in Pharmaceutical Composition

Introduction

Wanxin Su is a notable inventor based in Xuzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the area of pain management. His innovative work focuses on addressing the challenges associated with morphine-induced analgesic tolerance.

Latest Patents

Wanxin Su holds a patent for a pharmaceutical composition and method aimed at relieving or eliminating morphine-induced analgesic tolerance. The patent discloses a pharmaceutical composition that includes a therapeutically effective amount of a short peptide and morphine as active ingredients, along with a pharmaceutically acceptable carrier. The short peptide consists of an amino acid sequence shown in SEQ ID NO: 1 or a pharmaceutically acceptable salt thereof. The method involves administering the short peptide and morphine to a subject simultaneously, injecting the short peptide followed by morphine, or administering a pharmaceutical composition that includes both.

Career Highlights

Wanxin Su is affiliated with Xuzhou Medical University, where he contributes to research and development in the pharmaceutical sciences. His work has garnered attention for its potential to improve pain management strategies and enhance patient outcomes.

Collaborations

Wanxin Su collaborates with esteemed colleagues, including Qiongyao Tang and Zhe Zhang, who contribute to his research endeavors and help advance the field of pharmaceutical innovation.

Conclusion

Wanxin Su's innovative contributions to pharmaceutical compositions demonstrate his commitment to improving pain management. His work has the potential to significantly impact the treatment of patients experiencing morphine-induced analgesic tolerance.